Literature DB >> 16418321

Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls.

Claudine Guilbault1, Jaroslav P Novak, Patricia Martin, Marie-Linda Boghdady, Zienab Saeed, Marie-Christine Guiot, Thomas J Hudson, Danuta Radzioch.   

Abstract

Cystic fibrosis (CF) is caused by a defect in the CF transmembrane conductance regulator (CFTR) protein that functions as a chloride channel. Dysfunction of the CFTR protein results in salty sweat, pancreatic insufficiency, intestinal obstruction, male infertility, and severe pulmonary disease. Most of the morbidity and mortality of CF patients results from pulmonary complications. Differences in susceptibility to bacterial infection and variable degree of CF lung disease among CF patients remain unexplained. Many phenotypic expressions of the disease do not directly correlate with the type of mutation in the Cftr gene. Using a unique CF mouse model that mimics aspects of human CF lung disease, we analyzed the differential gene expression pattern between the normal lungs of wild-type mice (WT) and the affected lungs of CFTR knockout mice (KO). Using microarray analysis followed by quantitation of candidate gene mRNA and protein expression, we identified many interesting genes involved in the development of CF lung disease in mice. These findings point to distinct mechanisms of gene expression regulation between mice with CF and control mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418321     DOI: 10.1152/physiolgenomics.00206.2005

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  13 in total

1.  Partial Restoration of CFTR Function in cftr-Null Mice following Targeted Cell Replacement Therapy.

Authors:  Pascal Duchesneau; Rickvinder Besla; Mathieu F Derouet; Li Guo; Golnaz Karoubi; Amanda Silberberg; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2017-02-08       Impact factor: 11.454

2.  Microarray analysis of Xenopus endoderm expressing Ptf1a.

Authors:  Cassandra K Bilogan; Marko E Horb
Journal:  Genesis       Date:  2012-08-16       Impact factor: 2.487

3.  Functional analysis of Rfx6 and mutant variants associated with neonatal diabetes.

Authors:  Esther J Pearl; Zeina Jarikji; Marko E Horb
Journal:  Dev Biol       Date:  2011-01-04       Impact factor: 3.582

Review 4.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

5.  Gene expression profiling and histomorphometric analyses of the early bone healing response around nanotextured implants.

Authors:  Rima M Wazen; Shingo Kuroda; Clarice Nishio; Karine Sellin; John B Brunski; Antonio Nanci
Journal:  Nanomedicine (Lond)       Date:  2013-01-03       Impact factor: 5.307

6.  The tetraspanin Tm4sf3 is localized to the ventral pancreas and regulates fusion of the dorsal and ventral pancreatic buds.

Authors:  Zeina Jarikji; Lori Dawn Horb; Farhana Shariff; Craig A Mandato; Ken W Y Cho; Marko E Horb
Journal:  Development       Date:  2009-04-29       Impact factor: 6.868

7.  Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.

Authors:  Gabriella Wojewodka; Juan B De Sanctis; Danuta Radzioch
Journal:  J Lipids       Date:  2010-12-28

8.  Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator.

Authors:  Sam Tirkos; Susan Newbigging; Van Nguyen; Mary Keet; Cameron Ackerley; Geraldine Kent; Richard F Rozmahel
Journal:  Respir Res       Date:  2006-03-29

9.  Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells.

Authors:  Yaqin Xu; Christine Tertilt; Anja Krause; Luis E N Quadri; Ronald G Crystal; Stefan Worgall
Journal:  Respir Res       Date:  2009-04-03

Review 10.  The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases.

Authors:  Zeeshan Sattar; Alnardo Lora; Bakr Jundi; Christopher Railwah; Patrick Geraghty
Journal:  Pulm Med       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.